World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
31043
World Ranking
14956
National Ranking
480

Overview

Patrice Viens is affiliated with Aix-Marseille University in France and focuses primarily on medicine, with a significant emphasis on oncology. Their body of research encompasses various subfields such as cancer research, economics and econometrics related to health, pediatrics, perinatology and child health, and pulmonary and respiratory medicine.

Their recent publications include studies on cancer care and outcomes, reflecting both clinical and economic perspectives. Notable papers are:

  • Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France (2021, ESMO Open)
  • Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors (2021, OncoImmunology)
  • Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial (2021, Genome Medicine)
  • The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017 (2021, European Journal of Cancer)
  • Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic Therapy (2023, Cancer Research Communications)

Patrice Viens collaborates frequently with a group of researchers, including:

  • François Bertucci
  • Anthony Gonçalvès
  • Pierre Dantin
  • Sarah Calvin
  • Pascal Finetti

Their frequent publication venues include:

  • Cancer Research
  • Bone Marrow Transplantation
  • European Journal of Cancer
  • Journal of Translational Medicine
  • ESMO Open

Research topics addressed by Patrice Viens revolve around several key areas:

  • Childhood Cancer Survivors' Quality of Life
  • Cancer survivorship and care
  • Economic and Financial Impacts of Cancer
  • Breast Cancer Treatment Studies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer

Best Publications

  • ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

    Christophe Ginestier;Min Hee Hur;Emmanuelle Charafe-Jauffret;Florence Monville

  • Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

    Emmanuelle Charafe-Jauffret;Christophe Ginestier;Flora Iovino;Julien Wicinski

  • A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

    David Cameron;Michelle Casey;Michael Press;Deborah Lindquist

  • Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

    Emmanuelle Charafe-Jauffret;Christophe Ginestier;Flora Iovino;Carole Tarpin

  • Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial

    Henri Roché;Pierre Fumoleau;Marc Spielmann;Jean-Luc Canon

  • Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

    Emilie Mamessier;Aude Sylvain;Marie-Laure Thibult;Gilles Houvenaeghel

  • How basal are triple-negative breast cancers?

    François Bertucci;Pascal Finetti;Nathalie Cervera;Benjamin Esterni

  • Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine

    Edith A. Perez;Guillermo Lerzo;Xavier Pivot;Eva Thomas

  • International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

    S. Dawood;S. D. Merajver;P. Viens;P. B. Vermeulen

  • Prognostic and predictive value of PDL1 expression in breast cancer

    Renaud Sabatier;Pascal Finetti;Emilie Mamessier;José Adelaide

  • Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma Group

    Jean-Yves Blay;Axel Le Cesne;Isabelle Ray-Coquard;Binh Bui

  • Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters.

    François Bertucci;Sébastien Salas;Séverine Eysteries;Valéry Nasser

  • Integrated profiling of basal and luminal breast cancers.

    José Adélaïde;Pascal Finetti;Ismahane Bekhouche;Laetitia Repellini

  • Recent Trends in Epidemiology of Brain Metastases: An Overview

    Emeline Tabouret;Olivier Chinot;Philippe Metellus;Agnès Tallet

  • Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

    Eva Thomas;Josep Tabernero;Monica Fornier;Pierfranco Conté

  • Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers

    François Bertucci;Pascal Finetti;Nathalie Cervera;Emmanuelle Charafe-Jauffret

  • Gene expression profiling of primary breast carcinomas using arrays of candidate genes

    Francois Bertucci;Remi Houlgatte;Daniel Birnbaum;Catherine Nguyen

  • Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast Cancer

    François Bertucci;Pascal Finetti;Jacques Rougemont;Emmanuelle Charafe-Jauffret

  • Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.

    Jocelyne Jacquemier;Christophe Ginestier;Jacques Rougemont;Valérie-Jeanne Bardou

  • A gene expression signature identifies two prognostic subgroups of basal breast cancer.

    Renaud Sabatier;Pascal Finetti;Nathalie Cervera;Eric Lambaudie

Frequent Co-Authors

François Bertucci
François Bertucci Aix-Marseille University
Jocelyne Jacquemier
Jocelyne Jacquemier Grenoble Alpes University
Mario Campone
Mario Campone Grenoble Alpes University
Daniel Olive
Daniel Olive Aix-Marseille University
Jean-Yves Pierga
Jean-Yves Pierga Institute Curie
Peter B. Vermeulen
Peter B. Vermeulen University of Antwerp

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those pursuing a career in medicine but seeking more flexible or accelerated routes, there are a variety of online options to consider. Whether you're an RN or just getting started, these pathways can help you advance your medical career while fitting education into your life.

rn to bsn programs without clinicals offer a great solution for working nurses who want to earn a bachelor’s degree with minimal in-person requirements. If you’re interested in further specialization, the shortest post master's dnp program options allow experienced nurses to earn a doctoral degree faster, building leadership skills and expanding career prospects.

For a less intensive path, you might research the easiest dnp program reddit users suggest, which can help balance study with work commitments. Alternatively, those looking for rapid entry into nursing can explore fast track medical lpn programs, ideal for starting a healthcare career quickly.

These online and accelerated programs offer more accessible, flexible, and efficient ways to achieve your healthcare career goals in the USA.

Best Scientists Citing Patrice Viens

Trending Scientists